Abstract:
Controlling the adverse effects of counterfeit pharmaceuticals requires ensuring the transparency of pharmaceutical supply chain. Blockchain technology has been widely recognized by supply chain researchers as an emerging technology for improving the transparency and security of supply chain. Although there is a surge of attention to blockchain technology in the supply chain domain, there is not much empirical evidence on the use of blockchain technology to support decision-making in the pharmaceutical supply chain. The purpose of this paper is to present a conceptual model that was developed to investigate the challenges of adopting blockchain technology to control the pharmaceutical supply chain while combating counterfeit pharmaceutical flow.
